| scholarly article | Q13442814 |
| P2093 | author name string | Yang Li | |
| Ying Xiong | |||
| Junqi He | |||
| Zhiyu Yang | |||
| Duiping Feng | |||
| Longyan Yang | |||
| Weihua Bian | |||
| Renyou Zhai | |||
| Junfang Zheng | |||
| Wenfang Yao | |||
| P2860 | cites work | EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity | Q22001537 |
| Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling | Q24298046 | ||
| PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling | Q24303571 | ||
| Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases | Q24305156 | ||
| ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation | Q24320321 | ||
| Wnt signalling via the epidermal growth factor receptor: a role in breast cancer? | Q24794064 | ||
| EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma | Q28182609 | ||
| Human Delta1-pyrroline-5-carboxylate synthase: function and regulation | Q28275915 | ||
| Epidermal growth factor-related peptides and their receptors in human malignancies | Q28293442 | ||
| Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. | Q28368422 | ||
| Tyrosine phosphorylation of ErbB4 is enhanced by PSD95 and repressed by protein tyrosine phosphatase receptor type Z | Q28582156 | ||
| Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis | Q28585214 | ||
| Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells | Q28592252 | ||
| The ErbB signaling network: receptor heterodimerization in development and cancer | Q29617919 | ||
| NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility | Q30479197 | ||
| Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors | Q33767107 | ||
| The Na(+)/H(+) exchanger regulatory factor 2 mediates phosphorylation of serum- and glucocorticoid-induced protein kinase 1 by 3-phosphoinositide-dependent protein kinase 1. | Q34155123 | ||
| EGFR signaling in breast cancer: bad to the bone. | Q34348232 | ||
| Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation | Q34620786 | ||
| Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1) | Q35633702 | ||
| Contact-dependent inhibition of EGFR signaling by Nf2/Merlin | Q36118464 | ||
| Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation | Q37150777 | ||
| The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface | Q37657288 | ||
| Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapies | Q37780779 | ||
| Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function | Q38304289 | ||
| Novel EGFR-TK inhibitor EKB-569 inhibits hepatocellular carcinoma cell proliferation by AKT and MAPK pathways | Q39431960 | ||
| Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells. | Q39493807 | ||
| Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex | Q39513352 | ||
| Mutant rat strain lacking D-amino-acid oxidase | Q39948749 | ||
| Pharmacological characterization of MP-412 (AV-412), a dual epidermal growth factor receptor and ErbB2 tyrosine kinase inhibitor | Q40077599 | ||
| Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors | Q40547930 | ||
| E-cadherin binding modulates EGF receptor activation | Q40606421 | ||
| Protein tyrosine kinases and cancer | Q41679383 | ||
| NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer | Q45092731 | ||
| The beta1-adrenergic receptor mediates extracellular signal-regulated kinase activation via Galphas | Q46225959 | ||
| Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells | Q46439526 | ||
| Investigating the function of three non-synonymous SNPs in EGFR gene: structural modelling and association with breast cancer. | Q46891260 | ||
| The PDZ domain protein CAL interacts with mGluR5a and modulates receptor expression | Q48423163 | ||
| Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors | Q50335607 | ||
| EGFR is involved in control of gastric cell proliferation through activation of MAPK and Src signalling pathways in early-weaned rats. | Q51886652 | ||
| Elastase-released Epidermal Growth Factor Recruits Epidermal Growth Factor Receptor and Extracellular Signal-regulated Kinases to Down-regulate Tropoelastin mRNA in Lung Fibroblasts | Q62083049 | ||
| P433 | issue | 5 | |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 2027-2035 | |
| P577 | publication date | 2012-04-04 | |
| P1433 | published in | Amino Acids | Q15757015 |
| P1476 | title | EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation | |
| P478 | volume | 43 |
| Q38902585 | A novel NHE1-centered signaling cassette drives epidermal growth factor receptor-dependent pancreatic tumor metastasis and is a target for combination therapy. |
| Q90273866 | Alteration in the sensitivity to crizotinib by Na+/H+ exchanger regulatory factor 1 is dependent to its subcellular localization in ALK-positive lung cancers |
| Q43106592 | Clinical significance of EBP50 overexpression assessed by quantum dot analysis in gastric cancer |
| Q42197616 | Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma |
| Q38966467 | EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway |
| Q33962655 | EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2. |
| Q47250144 | EBP50 suppresses the proliferation of MCF-7 human breast cancer cells via promoting Beclin-1/p62-mediated lysosomal degradation of c-Myc. |
| Q26800001 | Insulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant disease |
| Q38505183 | Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network. |
| Q35128221 | Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes |
| Q37584289 | Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma |
| Q49894086 | NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings |
| Q55315464 | NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression. |
| Q54112426 | Na+/H+ exchanger regulatory factor 1 overexpression suppresses the malignant phenotype of MIAPaCa-2 pancreatic adenocarcinoma cells by downregulating Akt phosphorylation. |
| Q42654081 | PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation |
| Q33597837 | Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells |
| Q37295377 | Regulation of ErbB2 localization and function in breast cancer cells by ERM proteins |
| Q55061344 | Regulation of β2-adrenergic receptor cell surface expression by interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL). |
| Q39076960 | Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance. |
| Q36808215 | SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells |
| Q36524074 | Targeting of NHERF1 through RNA interference inhibits the proliferation and migration of metastatic prostate cancer cells |
| Q98464897 | The Functional Role of Voltage-Gated Sodium Channel Nav1.5 in Metastatic Breast Cancer |
Search more.